Fibroblast growth factor 21 is not required for the antidiabetic actions of the thiazoladinediones

Fibroblast growth factor 21 is an emerging metabolic regulator that was recently proposed to be a fed-state inducible factor in adipose tissue. As mice lacking FGF21 were refractory to treatment with rosiglitazone, FGF21 was suggested to underlie PPARγ-driven pharmacology and side effect profile (Du...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Adams, Andrew C., Coskun, Tamer, Cheng, Christine C., O′Farrell, Libbey S., DuBois, Susan L., Kharitonenkov, Alexei
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2013
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3773835/
https://ncbi.nlm.nih.gov/pubmed/24049735
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2013.05.005
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items